FDA Inspection 1166518 — Nippon Sanso Matheson, Inc.

Nippon Sanso Matheson, Inc. — FEI 3006376135

The FDA completed an inspection of Nippon Sanso Matheson, Inc. on Mar 11, 2022 in Vernon, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 11, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Vernon, CA (United States)